The burgeoning virtual marketplace has presented novel avenues for accessing prescription medications, including the stimulant Adderall, primarily administered for attention deficit hyperactivity disorder (ADHD). While supporters of cognitive enhancement argue that these substances can augment focus and productivity, ethical concerns arise surround